Fig. 8From: GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancersA Average expression of respective genes in each sample in control or TIGIT inhibitor-treated TFh-like cells with MAST DE adjusted p. B Cohen’s effect size and p of t-test comparison of pathway activity between control and treated TFh-like cells from each individual sample. C, D Average expression of respective genes in each sample in control or TIGIT inhibitor-treated C Treg cells and D DCs with MAST DE adjusted p. E Cohen’s effect size and p of t-test comparison of pathway activity between control and treated tumor epithelial cells from each individual sample. F Schematic representation summarizing the ex vivo effects of TIGIT antagonist in the TMEBack to article page